Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Laureate Enters Into Contract With ZZ Biotech
Laureate Pharma has entered into a development and manufacturing agreement with ZZ Biotech. As per the agreement, Laureate will produce activated protein C variant under cGMP conditions. Robert
Laureate Pharma has entered into a development and manufacturing agreement with ZZ Biotech. As per the agreement, Laureate will produce activated protein C variant under cGMP conditions. Robert
Athera Biotechnologies, an atherosclerosis R&D company developing novel products for treatment and prevention of cardiovascular disease (CVD), and ALPCO, a company providing quality research immunoassays, have signed a
EnWave has announced that it has dried three different antibodies in the company’s prototype freezeREV vial dehydration technology. Results from the study showed no detectable visual difference between
GeoVax Labs has announced the partial success in the recently completed phase 3 trial in Thailand of a candidate HIV/AIDS vaccine owned by Sanofi-Aventis and Global Solutions for
Nycomed is planning to build a plant to manufacture active pharmaceutical ingredients (APIs) and has already finished dosage forms for the Russian pharmaceutical market as well as the
Reportedly, the US and Chinese governments have approved H1N1 vaccines for use, which will begin next month. The UK government has also reported that the immunisation program is
GlaxoSmithKline has engaged Lazard and Co. with an intention to expand in India. Lazard and Co. will evaluate potential acquisitions in Inida. GSK is reportedly more interested in
The Medical Research Council (MRC), a UK-based, publicly-funded organization has presented the initial results of the independent phase III COINa study, which did not meet its primary endpoint
Central Drugs Standard Control Organization (CDSCO) in the Karnataka has set up a new office, which brings relief to the pharmaceutical companies. Now the state has two CDSCO
TAKE Solutions, a supply chain management and life sciences products company, has signed a deal with Chennai-based Novel Therapeutics. Reportedly, this is TAKE Solutions’ first deal in Chennai